HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mittelman, S. D. Articles by Bergman, R. N. Search for Related Content PubMed PubMed Citation Articles by Mittelman, S. D. Articles by Bergman, R. N. Social Bookmarking                What's this?

Extreme Insulin Resistance of the Central Adipose Depot In Vivo

From the Keck School of Medicine, University of Southern California, Department of Physiology and Biophysics, Los Angeles, California

Despite the well-described association between obesity and insulin resistance, the physiologic mechanisms that link these two states are poorly understood. The present study was performed to elucidate the role of visceral adipose tissue in whole-body glucose homeostasis. Dogs made abdominally obese with a moderately elevated fat diet had catheters placed into the superior mesenteric artery so that the visceral adipose bed could be insulinized discretely. Omental insulin infusion was extracted at 27%, such that systemic insulin levels were lower than in control (portal vein) insulin infusions. Omental infusion did not lower systemic free fatty acid levels further than control infusion, likely because of the resistance of the omental adipose tissue to insulin suppression and the confounding lower systemic insulin levels. The arteriovenous difference technique showed that local infusion of insulin did suppress omental lipolysis, but only at extremely high insulin concentrations. The median effective dose for suppression of lipolysis was almost fourfold higher in the visceral adipose bed than for whole-body suppression of lipolysis. Thus, the omental adipose bed represents a highly insulin-resistant depot that drains directly into the portal vein. Increased free fatty acid flux to the liver may account for hepatic insulin resistance in the moderately obese state.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				A. J. Smith, B. R. Thompson, M. A. Sanders, and D. A. Bernlohr Interaction of the Adipocyte Fatty Acid-binding Protein with the Hormone-sensitive Lipase: REGULATION BY FATTY ACIDS AND PHOSPHORYLATION J. Biol. Chem., November 2, 2007; 282(44): 32424 - 32432. [Abstract] [Full Text] [PDF]

				E. L. Melanson, W. T. Donahoo, G. K. Grunwald, and R. Schwartz Changes in 24-h substrate oxidation in older and younger men in response to exercise J Appl Physiol, November 1, 2007; 103(5): 1576 - 1582. [Abstract] [Full Text] [PDF]

				H. Yoshii, T. K. T. Lam, N. Gupta, T. Goh, C. A. Haber, H. Uchino, T. T. Y. Kim, V. Z. Chong, K. Shah, I. G. Fantus, et al. Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1089 - E1097. [Abstract] [Full Text] [PDF]

				G. Boden, P. She, M. Mozzoli, P. Cheung, K. Gumireddy, P. Reddy, X. Xiang, Z. Luo, and N. Ruderman Free Fatty Acids Produce Insulin Resistance and Activate the Proinflammatory Nuclear Factor-{kappa}B Pathway in Rat Liver Diabetes, December 1, 2005; 54(12): 3458 - 3465. [Abstract] [Full Text] [PDF]

				M. Ader, S. P. Kim, K. J. Catalano, V. Ionut, K. Hucking, J. M. Richey, M. Kabir, and R. N. Bergman Metabolic Dysregulation With Atypical Antipsychotics Occurs in the Absence of Underlying Disease A Placebo-Controlled Study of Olanzapine and Risperidone in Dogs Diabetes, March 1, 2005; 54(3): 862 - 871. [Abstract] [Full Text] [PDF]

				M. Kabir, K. J. Catalano, S. Ananthnarayan, S. P. Kim, G. W. Van Citters, M. K. Dea, and R. N. Bergman Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E454 - E461. [Abstract] [Full Text] [PDF]

				A. Gastaldelli, Y. Miyazaki, M. Pettiti, E. Buzzigoli, S. Mahankali, E. Ferrannini, and R. A. DeFronzo Separate Contribution of Diabetes, Total Fat Mass, and Fat Topography to Glucose Production, Gluconeogenesis, and Glycogenolysis J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3914 - 3921. [Abstract] [Full Text] [PDF]

				J. S. Rand, L. M. Fleeman, H. A. Farrow, D. J. Appleton, and R. Lederer Canine and Feline Diabetes Mellitus: Nature or Nurture? J. Nutr., August 1, 2004; 134(8): 2072S - 2080S. [Abstract] [Full Text] [PDF]

				R. Buettner, I. Ottinger, J. Scholmerich, and L. C. Bollheimer Preserved direct hepatic insulin action in rats with diet-induced hepatic steatosis Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E828 - E833. [Abstract] [Full Text] [PDF]

				M. Laudes, I. Barroso, J.'a. Luan, M. A. Soos, G. Yeo, A. Meirhaeghe, L. Logie, A. Vidal-Puig, A. J. Schafer, N. J. Wareham, et al. Genetic Variants in Human Sterol Regulatory Element Binding Protein-1c in Syndromes of Severe Insulin Resistance and Type 2 Diabetes Diabetes, March 1, 2004; 53(3): 842 - 846. [Abstract] [Full Text] [PDF]

				S. P. Kim, M. Ellmerer, G. W. Van Citters, and R. N. Bergman Primacy of Hepatic Insulin Resistance in the Development of the Metabolic Syndrome Induced by an Isocaloric Moderate-Fat Diet in the Dog Diabetes, October 1, 2003; 52(10): 2453 - 2460. [Abstract] [Full Text] [PDF]

				M. E. Cleasby, P. A. T. Kelly, B. R. Walker, and J. R. Seckl Programming of Rat Muscle and Fat Metabolism by in Utero Overexposure to Glucocorticoids Endocrinology, March 1, 2003; 144(3): 999 - 1007. [Abstract] [Full Text] [PDF]